Gene · 2642
Papers2,157
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,157
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Incretin and Glucagon Signalling in MASLD and MASH: Integrating Metabolic Pathways With Disease Progression. | Diabetes Obes Metab | 2026 | 41816810 | PubTator, text mining | PubMed |
| Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification. | Small Sci | 2026 | 41810046 | PubTator, text mining | PubMed |
| Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non-Diabetic Adults: A Meta-Analysis of Randomised Controlled Trials. | Diabetes Obes Metab | 2026 | 41804840 | PubTator, text mining | PubMed |
| Extracellular domain-dependent modulation of class B1 G-protein-coupled receptor signaling. | Mol Pharmacol | 2026 | 41795246 | PubTator, text mining | PubMed |
| Cardiac neurons expressing a glucagon-like receptor mediate cardiac arrhythmia induced by high-fat diet in Drosophila. | Elife | 2026 | 41789689 | PubTator, text mining | PubMed |
| Comparative Efficacy and Safety of Glucagon Receptor Agonists on Metabolic Outcomes: A Network Meta-Analysis of Randomised Controlled Trials. | Endocrinol Diabetes Metab | 2026 | 41787737 | PubTator, text mining | PubMed |
| Retatrutide in type 2 diabetes mellitus and obesity: an overview. | Expert Rev Clin Pharmacol | 2026 | 41785010 | PubTator, text mining | PubMed |
| Glucagon-like peptide-1 and dual/triple receptor agonists in the treatment of metabolic dysfunction-associated steatotic liver disease: advances in mechanistic research. | Front Med (Lausanne) | 2026 | 41767516 | PubTator, text mining | PubMed |
| Baseline glucose-to-lymphocyte ratio predicts nivolumab outcomes in advanced non-small cell lung cancer: a multicenter retrospective study. | Front Immunol | 2026 | 41766853 | PubTator, text mining | PubMed |
| A Global Perspective on Metabolic Dysfunction-Associated Steatotic Liver Disease: From Molecular Mechanisms to Therapeutic Strategy Innovation. | Nutrients | 2026 | 41754196 | PubTator, text mining | PubMed |
| Incretin-Based Therapies: A Novel Pathway in Addiction Treatment. | J Clin Med | 2026 | 41753300 | PubTator, text mining | PubMed |
| Preoperative Gamma-Glutamyltransferase-to-Lymphocyte Ratio as an Independent Prognostic Biomarker in Patients Undergoing Radical Cystectomy for Bladder Cancer. | Medicina (Kaunas) | 2026 | 41752742 | PubTator, text mining | PubMed |
| MASH in Type 2 Diabetes: Pathophysiology, Diagnosis, and Therapeutic Management-A Narrative Review. | Medicina (Kaunas) | 2026 | 41752724 | PubTator, text mining | PubMed |
| Reexamining Fat: Exploring Diversity, Plasticity, Development, Functional Implication, and Therapeutic Options. | Int J Mol Sci | 2026 | 41752060 | PubTator, text mining | PubMed |
| The Multifaceted Nature of GLP-1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases. | Int J Mol Sci | 2026 | 41752021 | PubTator, text mining | PubMed |
| Identification and Functional Validation of PTH2R as a Therapeutic Target in Lung Adenocarcinoma. | Biomedicines | 2026 | 41751388 | PubTator, text mining | PubMed |
| Glucagon-like Peptide Receptor Agonists and Kidney Outcomes in the Era of Personalized Medicine: Focus on Albuminuria. | J Pers Med | 2026 | 41745389 | PubTator, text mining | PubMed |
| Preoperative gamma-glutamyl transferase to lymphocyte ratio predicts recurrence in non-muscle-invasive bladder cancer. | Front Oncol | 2026 | 41743958 | PubTator, text mining | PubMed |
| Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy men. | Endocr Connect | 2026 | 41738774 | PubTator, text mining | PubMed |
| Individualisation of Exercise Prescription in Cancer: A Systematic Review and Meta-Analysis. | Sports Med Open | 2026 | 41733868 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2642/papers?page=4